DE602007005244D1 - N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung - Google Patents
N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendungInfo
- Publication number
- DE602007005244D1 DE602007005244D1 DE602007005244T DE602007005244T DE602007005244D1 DE 602007005244 D1 DE602007005244 D1 DE 602007005244D1 DE 602007005244 T DE602007005244 T DE 602007005244T DE 602007005244 T DE602007005244 T DE 602007005244T DE 602007005244 D1 DE602007005244 D1 DE 602007005244D1
- Authority
- DE
- Germany
- Prior art keywords
- pyrrolidinone
- phenyl
- carbamoylmethyl
- preparation
- pharmaceutical use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-06-45A LV13630B (en) | 2006-03-16 | 2006-03-16 | Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone |
PCT/EP2007/052424 WO2007104780A2 (en) | 2006-03-16 | 2007-03-15 | N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602007005244D1 true DE602007005244D1 (de) | 2010-04-22 |
Family
ID=38461010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602007005244T Active DE602007005244D1 (de) | 2006-03-16 | 2007-03-15 | N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung |
Country Status (21)
Country | Link |
---|---|
US (2) | US9102615B2 (de) |
EP (1) | EP2013166B1 (de) |
CN (1) | CN101448786A (de) |
AT (1) | ATE460396T1 (de) |
CA (1) | CA2647206C (de) |
CY (1) | CY1110170T1 (de) |
DE (1) | DE602007005244D1 (de) |
DK (1) | DK2013166T3 (de) |
EA (1) | EA014668B1 (de) |
EE (1) | EE05536B1 (de) |
ES (1) | ES2342024T3 (de) |
GE (1) | GEP20104915B (de) |
HR (1) | HRP20090524C1 (de) |
LT (1) | LT5589B (de) |
LV (1) | LV13630B (de) |
ME (1) | ME01192B (de) |
PL (1) | PL2013166T3 (de) |
PT (1) | PT2013166E (de) |
SI (1) | SI2013166T1 (de) |
UA (1) | UA96440C2 (de) |
WO (1) | WO2007104780A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LV14346B (lv) | 2009-11-05 | 2011-07-20 | Grindeks, A/S | 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti |
WO2012123358A1 (en) | 2011-03-11 | 2012-09-20 | Grindeks | 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
RU2480214C1 (ru) * | 2011-09-22 | 2013-04-27 | Валентина Ивановна Ахапкина | Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов |
EP2847207B1 (de) | 2012-05-08 | 2019-03-27 | Nicox Ophthalmics, Inc. | Nanokristalle von Fluticasonpropionat |
TW201408294A (zh) | 2012-07-05 | 2014-03-01 | Merz Pharma Gmbh & Co Kgaa | (r)-苯基披喇瑟盪於治療帕金森氏症之用除 |
TW201408293A (zh) | 2012-07-05 | 2014-03-01 | Merz Pharma Gmbh & Co Kgaa | (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途 |
LV15003B (lv) * | 2013-10-22 | 2015-08-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei |
LV15015B (lv) | 2013-12-13 | 2015-12-20 | Olainfarm, A/S | 3-karboksi-4-(R)-fenilpirolidin-2-ona sāls un tā pielietošana |
LV15016B (lv) | 2013-12-18 | 2016-01-20 | Olainfarm, A/S | N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas |
EP2891491A1 (de) | 2014-01-03 | 2015-07-08 | Merz Pharma GmbH & Co. KGaA | Verwendung von (R)-Phenylpiracetam zur Behandlung von Schlafstörungen |
LV15072B (lv) | 2014-05-14 | 2016-09-20 | Olainfarm, A/S | Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai |
EP3127539A1 (de) | 2015-08-03 | 2017-02-08 | Latvian Institute Of Organic Synthesis | Verwendung von 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamid bei der behandlung von anfällen |
WO2024049236A1 (ko) * | 2022-08-31 | 2024-03-07 | 고려대학교 산학협력단 | 키랄 감마 락탐 유도체 또는 이의 약학적으로 허용가능한 염 및 이의 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
RU2232578C1 (ru) * | 2003-04-10 | 2004-07-20 | Ахапкина Валентина Ивановна | Вещество, обладающее антидепрессивной активностью |
RU2289404C1 (ru) * | 2005-04-06 | 2006-12-20 | ГОУ ВПО "Московский государственный медико-стоматологический университет Министерства здравоохранения РФ" | Способ премедикации у пациентов со средним уровнем психоэмоционального напряжения при амбулаторных стоматологических вмешательствах |
-
2006
- 2006-03-16 LV LVP-06-45A patent/LV13630B/en unknown
-
2007
- 2007-03-15 GE GEAP200710934A patent/GEP20104915B/en unknown
- 2007-03-15 CA CA2647206A patent/CA2647206C/en not_active Expired - Fee Related
- 2007-03-15 DK DK07726915.7T patent/DK2013166T3/da active
- 2007-03-15 DE DE602007005244T patent/DE602007005244D1/de active Active
- 2007-03-15 EA EA200801978A patent/EA014668B1/ru not_active IP Right Cessation
- 2007-03-15 ME MEP-2009-293A patent/ME01192B/me unknown
- 2007-03-15 WO PCT/EP2007/052424 patent/WO2007104780A2/en active Application Filing
- 2007-03-15 PL PL07726915T patent/PL2013166T3/pl unknown
- 2007-03-15 US US12/226,332 patent/US9102615B2/en not_active Expired - Fee Related
- 2007-03-15 AT AT07726915T patent/ATE460396T1/de active
- 2007-03-15 SI SI200730253T patent/SI2013166T1/sl unknown
- 2007-03-15 PT PT07726915T patent/PT2013166E/pt unknown
- 2007-03-15 EE EEP200800063A patent/EE05536B1/xx not_active IP Right Cessation
- 2007-03-15 EP EP07726915A patent/EP2013166B1/de active Active
- 2007-03-15 ES ES07726915T patent/ES2342024T3/es active Active
- 2007-03-15 UA UAA200812099A patent/UA96440C2/ru unknown
- 2007-03-15 CN CNA2007800177832A patent/CN101448786A/zh active Pending
-
2008
- 2008-09-22 LT LT2008075A patent/LT5589B/lt not_active IP Right Cessation
-
2009
- 2009-09-30 HR HRP20090524AA patent/HRP20090524C1/hr not_active IP Right Cessation
-
2010
- 2010-06-08 CY CY20101100506T patent/CY1110170T1/el unknown
-
2015
- 2015-04-16 US US14/688,633 patent/US9382203B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ATE460396T1 (de) | 2010-03-15 |
SI2013166T1 (sl) | 2010-07-30 |
ME01192B (me) | 2012-12-20 |
GEP20104915B (en) | 2010-03-10 |
UA96440C2 (ru) | 2011-11-10 |
US9102615B2 (en) | 2015-08-11 |
WO2007104780A2 (en) | 2007-09-20 |
LV13630B (en) | 2007-12-20 |
US9382203B2 (en) | 2016-07-05 |
HRPK20090524B3 (hr) | 2012-12-31 |
CN101448786A (zh) | 2009-06-03 |
EA200801978A1 (ru) | 2009-04-28 |
EE200800063A (et) | 2008-12-15 |
ES2342024T3 (es) | 2010-06-30 |
LT2008075A (en) | 2009-06-25 |
EP2013166B1 (de) | 2010-03-10 |
HRP20090524C1 (hr) | 2017-03-10 |
EP2013166A2 (de) | 2009-01-14 |
WO2007104780A3 (en) | 2007-11-29 |
EE05536B1 (et) | 2012-04-16 |
CY1110170T1 (el) | 2015-01-14 |
HRP20090524A2 (hr) | 2009-12-31 |
DK2013166T3 (da) | 2010-07-05 |
US20100022784A1 (en) | 2010-01-28 |
CA2647206A1 (en) | 2007-09-20 |
PT2013166E (pt) | 2010-06-09 |
CA2647206C (en) | 2011-09-27 |
PL2013166T3 (pl) | 2010-08-31 |
US20150216846A1 (en) | 2015-08-06 |
EA014668B1 (ru) | 2010-12-30 |
LT5589B (lt) | 2009-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602007005244D1 (de) | N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung | |
IL180286A0 (en) | Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
ZA200700709B (en) | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
DE502005010912D1 (de) | Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
ATE482207T1 (de) | Cyclische harnstoffderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung als kinaseinhibitoren | |
ATE433958T1 (de) | Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung | |
DE502005007786D1 (de) | Ausgewahlte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
ATE381564T1 (de) | Arylsubstituierte polycyclische amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE502005010105D1 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
WO2010004197A3 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
EP1781296A4 (de) | Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie | |
WO2007016352A3 (en) | Oral liquid losartan compositions | |
IL192442A0 (en) | Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
DE102009035301A8 (de) | Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung | |
DE602005018911D1 (de) | 1,4-Dihydropyridine-kondensierte Heterocyclen Verfahren zu deren Herstellung sowie Verwendung und Zusammensetzungen dergleichen | |
ATE538125T1 (de) | Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren | |
DE602005006489D1 (de) | Polycarbosilan und Verfahren zu dessen Herstellung | |
DE602004029245D1 (de) | Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen | |
DE602005011818D1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
ATE462408T1 (de) | Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung | |
DK2185561T3 (da) | Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf | |
DE602005002776D1 (de) | Verfahren zur Herstellung von 1,3-Dihydro-2H-3-Benzazepin-2-on und Anwendung zur Herstellung von Ivabradine und ihren pharmazeutischen annehmbaren Salzen | |
DE602004012275D1 (de) | zu dessen Herstellung und Impstoffderivate davon | |
ZA201005397B (en) | 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative,use thereof,and medicament containing said derivative | |
BRPI0905875A2 (pt) | "composição, método de preparação de uma composição farmacêutica e uso de uma composição" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |